Medifast
MED
132 hedge funds and large institutions have $373M invested in Medifast in 2014 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 34 increasing their positions, 50 reducing their positions, and 16 closing their positions.
300% more funds holding in top 10
Funds holding in top 10: 1 → 4 (+3)
44% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 16
26% more call options, than puts
Call options by funds: $8.18M | Put options by funds: $6.5M
20% more capital invested
Capital invested by funds: $311M → $373M (+$61.7M)
12.02% more ownership
Funds ownership: 85.54% → 97.56% (+12%)
4% more funds holding
Funds holding: 127 → 132 (+5)
32% less repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 50
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Coliseum Capital Management
Rowayton,
Connecticut
|
+$21.8M |
| 2 |
EC
Engaged Capital
Newport Beach,
California
|
+$16.1M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$9.38M |
| 4 |
Two Sigma Investments
New York
|
+$4.14M |
| 5 |
CCA
Conestoga Capital Advisors
Wayne,
Pennsylvania
|
+$3.08M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSW
Thompson Siegel & Walmsley
Richmond,
Virginia
|
-$17.5M |
| 2 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$6.2M |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$5.86M |
| 4 |
Millennium Management
New York
|
-$3.04M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
-$2.87M |
MED Hedge Fund Activity: Q1 2014 in Review
132 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Medifast (MED) for Q1 2014, worth a combined $373M — up 20% from $311M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new MED positions and 16 closed out — a net gain of 7 holders — while 34 added to existing stakes and 50 trimmed.
The largest buyer was Coliseum Capital Management, opening a new position worth an estimated $21.8M. The largest seller was Thompson Siegel & Walmsley, exiting entirely with an estimated $17.5M sold.
- 132 institutional investors held Medifast (MED) as of Q1 2014, up from 127 in Q4 2013.
- Funds reported $373M of Medifast stock for Q1 2014, up 20% quarter-over-quarter.
- 23 funds opened new Medifast positions in Q1 2014 and 16 closed out, a net change of +7 holders.
- The largest Medifast buyer in Q1 2014 was Coliseum Capital Management, an estimated $21.8M added.
- The largest Medifast seller in Q1 2014 was Thompson Siegel & Walmsley, an estimated $17.5M sold.
Based on aggregated 13F filings for Q1 2014.